استمرار التوسع الدولي كمحرك رئيسي [...] Read more »
Estithmar Holding Reports 66% Revenue Growth to QAR 4.9 Bn and 99% Increase in Net Profit to QAR 703 Mn for the Nine Months Ended September 30, 2025
- Continued International Expansion Drives Sustained Growth
- All Key [...] Read more »
Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates
- FDA provides pivotal agreement on EB613 Phase 3 design, confirming Bone Mineral Density [...] Read more »
Swvl Grows 12.4% Quarter on Quarter in IFRS Revenue, 47% Quarter on Quarter Growth in Revenue in Constant Currency, and Achieves $0.8 Million in Net Profit in Q1 2025
Revenue growth of 12.4%, and 47% in constant currency for Q1 2025 over Q1 2024
Achieved $0.8 million in Net Profit in Q1 2025
Dollar pegged revenue increased [...] Read more »
Entera Bio Announces First Quarter 2025 Financial Results and Business Updates
JERUSALEM, May 09, 2025 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key business updates for [...] Read more »